Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 544 participants.
Also called NCT07929818
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 544 participants
- Sponsor
- Hussain Aziz Bhatti
- Registry
-
NCT07929818
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT07929818. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2026-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery
- Condition
- Spinal Anesthesia
- Condition
- Intraoperative Hypotension
- Condition
- Bradycardia
- Intervention (Drug)
- Dexmedetomidine 5 micrograms (intrathecal)
- Intervention (Drug)
- Dexmedetomidine 10 micrograms (intrathecal)
- Intervention (Drug)
- Hyperbaric bupivacaine 0.5%
- Lead sponsor
- Hussain Aziz Bhatti
Record details
- Record id
cardio:ct-nct07929818- Content hash
7ec39522bcd9b018b7ccc9bcd40bf83165052ef3f9e43808d6c6683658604134